Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,302,546
-$22,966,088 QoQ
Shares Held
303,624
-88.8% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. NUVB ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in NUVB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,302,546 | 303,624 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,268,634 | 2,708,553 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,052,442 | 284,444 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $540,774 | 277,320 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $408,004 | 231,821 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $598,566 | 225,025 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $492,961 | 215,267 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $643,331 | 220,319 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,930,860 | 1,354,632 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $313,835 | 207,838 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $1,061,160 | 791,911 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,450,474 | 805,819 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,418,746 | 854,667 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,679,686 | 874,837 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,041,833 | 911,533 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $275,746 | 85,107 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $265,388 | 50,454 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $316,557 | 37,242 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $139,915 | 14,076 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $106,906 | 11,483 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||